GM-CSF Protein (AA 18-144)
Quick Overview for GM-CSF Protein (AA 18-144) (ABIN2017905)
Target
See all GM-CSF (CSF2) ProteinsProtein Type
Biological Activity
Origin
Source
Purity
- 
    - 
                                            Protein Characteristics
- AA 18-144
- 
                                            Characteristics
- ED50 < 0.2 ng/mL, measured in a cell proliferation assay using TF-1 cells, corresponding to a specific activity of > 5x10^6 units/mg.
- 
                                            Endotoxin Level
- < 0.2 EU/μg, determined by LAL method.
 
- 
                                            
- 
    Want other Options for this Protein ?!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions 
- 
    
- 
    - 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Lyophilized
- 
                                            Reconstitution
- Reconstituted in ddH2O or PBS at 100 μg/mL.
- 
                                            Buffer
- Lyophilized after extensive dialysis against PBS.
- 
                                            Storage
- -80 °C
- 
                                            Storage Comment
- Lyophilized recombinant human Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) remains stable up to 6 months at -80 °C from date of receipt. Upon reconstitution, rhGM-CSF should be stable up to 1 week at 4 °C or up to 2 months at -20 °C.
- 
                                            Expiry Date
- 6 months
 
- 
                                            
- 
    - GM-CSF (CSF2) (Colony Stimulating Factor 2 (Granulocyte-Macrophage) (CSF2))
- 
                                            Alternative Name
- Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF)
- 
                                            Background
- 
                        Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) was initially characterized as a growth factor that can support the in vitro colony formation of granulocyte-macrophage progenitors. Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) is produced by a number of different cell types, including activated T cells, B cells, macrophages, mast cells, endothelial cells, and fibroblasts, in response to cytokine of immune and inflammatory stimuli. Besides granulocyte-macrophage progenitors, Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) is a growth factor for erythroid, megakaryocyte, and eosinophil progenitors. On mature hematopoietic cells, GM-CSF is a survival factor for and activates the effectors functions of granulocytes,monocytes/macrophages and eosinophils. Human Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) can induce human endothelial cells to migrate and proliferate. Additionally, Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) can stimulate the proliferation of a number of tumor cell lines, including osteogenic sarcoma, carcinoma, and adenocarcinoma cell lines.
 Synonyms: Granulocyte/Macrophage Colony-Stimulating Factor, CSF-2, MGI-1GM, pluripoietin-alpha
- 
                                            Molecular Weight
- 22-28 kDa, observed by non-reducing SDS-PAGE.
- 
                                            Pathways
- JAK-STAT Signaling, Cellular Response to Molecule of Bacterial Origin
 Target
- 
                    
 
                                     
                                     
                                    